페르골리드

용도

• Equine 'Cushing's-like' Disease [pituitary pars intermedia dysfunction (PPID)]
• Equine 'Cushing's-like' Disease [pituitary pars intermedia dysfunction (PPID)]
• Equine 'Cushing's-like' Disease [pituitary pars intermedia dysfunction (PPID)]

투여 방법

가능한 부작용

• Anorexia/decreased appetite (up to 10% of horses during the first week)
• Colic (rare)
• Diarrhea (rare)
• Lethargy (dogs)
• Vomiting (dogs)
• Hypertension (dogs)
• Ptosis (dogs)

주의사항 및 금기

• Hypersensitivity to pergolide or other ergot derivatives
• Safety in pregnant horses has not been established. May interfere with lactation due to its ergot-derivative nature. Compounded aqueous suspensions are highly unstable; they must be stored in dark containers, refrigerated, and discarded after 30 days or if any color change occurs.

약물 상호작용

• Dopamine antagonists (e.g., phenothiazines): May decrease the effects of pergolide
• Metoclopramide: May decrease the effects of pergolide

자주 묻는 질문